Skip to content

Assembly Biosciences ASMB Q4 2024 Annual earnings

Reported March 20, 2025 · Before market open

Revenue$7.4MBeat by $3.8M
EPS-$1.57Beat by $0.18
Revenue estimate$3.6M
EPS estimate-$1.75

Next report

Aug 5, 2026 (In 1 week)
Revenue estimate$8.6M
EPS estimate-$0.70

Financials

Q4 2024

Income statement

See full
Revenue$7.4M+2.7%
Operating income-$11.5M+8.1%
Net income-$10.3M+5.7%
EPS (diluted)-$1.57+11.3%

Balance sheet

See full
Cash & equivalents$38.3M+93.3%
Total debt$3.1M+31.9%
Total equity$33.4M-18.8%
Total assets$119.2M-12.9%

Cash flow

See full
Operating cash flow-$407.0K-101%
Free cash flow-$407.0K-101%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$100.3M+85.9%
Enterprise value$65.05M+78.4%
P/S3.5×-4.0×

Profitability

See full
Operating margin-159.3%-71.9pp
Net margin-140.9%-64.1pp
FCF margin-179.3%-493pp

Returns & leverage

See full
Return on equity-107.9%+10.8pp
Debt / equity0.1×0.0×
Current ratio2.4×-1.0×

Versus estimates

Ask the moment Assembly Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Assembly Biosciences report Q4 2024 earnings?
Assembly Biosciences (ASMB) reported Q4 2024 earnings on March 20, 2025 before market open.
What were Assembly Biosciences's Q4 2024 revenue and EPS?
Assembly Biosciences reported revenue of $7.4M and eps of $-1.57 for Q4 2024.
Did Assembly Biosciences beat estimates in Q4 2024?
Revenue beat the consensus estimate of $3.6M by $3.8M. EPS beat the consensus estimate of $-1.75 by $0.18.
Where can I find Assembly Biosciences's Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-042673) directly on SEC EDGAR. The filing index links above go to sec.gov.